Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: ease (133), lessen (22), improve (762)

Daratumumab SC Ver1

Description: Chemotherapy Protocol Myeloma Daratumumab Subcutaneous Regimen • Myeloma – Daratumumab (SC) Indication • Daratumumab monotherapy is recommended as an option for treating relapsed and
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Daratumumab-SC-Ver1.pdf

DRD Daratumumab-Lenalidomide-Dexamethasone

Description: Chemotherapy Protocol Myeloma DRD Daratumumab-Lenalidomide-Dexamethasone Regimen • Myeloma – DRD Daratumumab-Lenalidomide-Dexamethasone Indication • Daratumumab in combination with lenalidomide and dexamethasone
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DRD-Daratumumab-Lenalidomide-Dexamethasone.pdf

DVdSC (weekly cycles1-8) Bortezomib-Daratumumab-Dexamethasone Ver1

Description: Chemotherapy Protocol Myeloma DVd SC (weekly cycles 1-8) Bortezomib-Daratumumab-Dexamethasone Regimen • Myeloma – DVd SC (weekly cycles 1-8) bortezomib
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DVdSC-weekly-cycles1-8-Bortezomib-Daratumumab-Dexamethasone-Ver1.pdf

DVd-T SC Bortezomib-Daratumumab-Dexamethasone-Thalidomide v1

Description: Details of the Chemotherapy Protocol for Myeloma.
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DVd-T-SC-Bortezomib-Daratumumab-Dexamethasone-Thalidomide.pdf

DVdSC (weekly cycles 9 onwards) DaratumumabSC-Bortezomib-Dexamethasone Ver1

Description: Chemotherapy Protocol Myeloma DVd SC (weekly) Bortezomib Daratumumab Dexamethasone Cycles 9 onwards Regimen • Myeloma – Bortezomib with daratumumab and dexamethasone Indication • Daratumumab
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DVdSC-weekly-cycles-9-onwards-DaratumumabSC-Bortezomib-Dexamethasone-Ver1.pdf

Iron supplements - patient information

Description: We have recommended that you take iron supplements because you are anaemic, or at risk of developing anaemia, because the iron
Url: /Media/UHS-website-2019/Patientinformation/Blooddisorders/Iron-supplements-1533-PIL.pdf

Doctrine of double effect

Description: Auto Generated Title It is inevitable that we cause our patients harm during our attempts to deal with their
Url: /HealthProfessionals/Clinical-law-updates/Doctrineofdoubleeffect.aspx

Tips on a speedier recovery after an operation - patient information

Description: This factsheet explains what to expect after having an operation and gives tips and exercises to help speed up your recovery
Url: /Media/UHS-website-2019/Patientinformation/Respiratory/Tips-on-a-speedier-recovery-after-an-operation-751-PIL.pdf

Parents participating in clinical ethics committees

Description: What is the role of a clinical ethics committee, and how much should patients' families be involved?
Url: /HealthProfessionals/Clinical-law-updates/Parents-participating-in-clinical-ethics-committees.aspx

Symptom and consequence: not interchangeable

Description: A court considers whether a patient with fluctuating capacity should be compelled to have haemodialysis at times when he refuses it
Url: /HealthProfessionals/Clinical-law-updates/Symptom-and-consequence-not-interchangeable.aspx

1 to 10 of 31

Previous 1 2 3 4 Next